Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £227.11m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Trading Update

20 Jan 2026 07:00

RNS Number : 5087P
Concurrent Technologies PLC
20 January 2026
 

 20 January 2026

 

 

Concurrent Technologies Plc

("Concurrent", the "Company" or the "Group")

 

Trading Update

 

Significant year-on-year growth driven by record order intake

 

Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems, and mission-critical solutions used in high-performance markets by some of the world's major OEMs, provides an update on trading for the year ended 31 December 2025 ("FY25").

 

Based on its unaudited management accounts, the Company expects both revenue and profit before tax to be in line with market expectations, delivering strong double-digit growth on FY24 (FY24: revenue £40.3m and profit before tax £5.2m).1 This reflects the growing momentum across the Group's Products and Systems business units, notwithstanding delays to US Department of Defense budget approvals and the recent US government shutdown.

 

Total order intake for FY25 was at a record level of approximately £47 million (FY24: £41 million), driven by particularly strong demand from customers in Europe and Asia-Pacific, reflecting the continued strengthening of Concurrent's reputation among leading global primes. The Group ended FY25 in a solid financial position with £14.4m of cash at bank (FY24: £13.7m), with elevated year-end debtors reflecting seasonally high invoicing.

 

In September, the Company announced a $5.2 million design services contract with a major defence prime contractor. A subsequent $1.0 million contract expansion has increased the total value to $6.2 million, making it Concurrent's largest single order to date. The expanded scope includes the design and supply of Automatic Test Equipment to support the customer's in-house production and testing, highlighting the early commercial success and growth potential of Concurrent's design services offering.

 

Outlook

The Company has entered the new financial year with good momentum, underpinned by robust customer demand, record order intake and a growing pipeline of design wins expected to convert into production revenues. This progress is supported by a solid balance sheet, providing the financial flexibility to continue investing as the Group delivers on its growth strategy in the year ahead, with strategic plans in place to manage component costs through the year as necessary.

 

Miles Adcock, CEO, commented: "FY25 was another strong year for Concurrent, in which we continued to execute on our stated strategy, as planned. With our new Los Angeles facilities now fully operational and the Colchester relocation expected to complete in H1 FY26, we believe the business is entering a new phase of operational capacity. We will see prior design wins begin translating into meaningful orders, while strengthening and diversifying our portfolio of products and services to support long-term growth. I am extremely proud of what our team has achieved and am excited by the scale of opportunity ahead."

 

1 As at 19 January 2026, The Board understands that market expectations for FY2025, based on published analyst forecasts, are for revenue of £46.0m, and profit before tax of £6.2m.

 

Enquiries:

Concurrent Technologies PlcMiles Adcock - CEO

Kim Garrod - CFO

 

 

 

+44 (0)1206 752626

Alma Strategic CommunicationsHannah Campbell

Josh Royston

Will Merison

 

 

+44 (0)20 3405 0205

Cavendish Capital Markets Limited (NOMAD)Neil McDonald

Peter Lynch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded plug-in cards and systems for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded operating systems. The products are sold world-wide.

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLMLTMTJBBTF
Date   Source Headline
14th May 20267:00 amRNSPosting of Annual Report and Notice of AGM
13th Apr 20267:01 amRNSBoard change
13th Apr 20267:00 amRNSFinal results for the year ended 31 December 2025
31st Mar 20265:24 pmRNSBlock Admission Application
30th Mar 20267:00 amRNSNotice of Results and Investor Presentation
10th Mar 20267:00 amRNSLaunch of Next-Generation Computing Products
25th Feb 20267:00 amRNSHolding(s) in Company
16th Feb 20267:00 amRNSAppointment of Nominated Adviser and Broker
27th Jan 20267:00 amRNSNew Managing Director of Products Appointed
26th Jan 20267:00 amRNSNew Product Announcement
20th Jan 20267:00 amRNSTrading Update
23rd Dec 20257:00 amRNSUpdate on Expanded HQ and Manufacturing Facility
23rd Dec 20257:00 amRNSUpdate on Expanded HQ and Manufacturing Facility
12th Dec 20254:43 pmRNSExercise of Options and TVR
9th Dec 202512:46 pmRNSExercise of Options, Director Dealing and TVR
5th Dec 202512:15 pmRNSExercise of Share Options and Total Voting Rights
27th Nov 20254:46 pmRNSExercise of Options, Director Dealing and TVR
1st Oct 20257:00 amRNSIssue of Share Options and PDMR Dealing
19th Sep 20255:36 pmRNSDirector Share Dealing
19th Sep 20257:00 amRNS$5.25m US Defence Contract Secured
8th Sep 20257:00 amRNSInterim Results
4th Sep 20257:00 amRNSRecord UK defence contract secured for £4m
20th Aug 20257:00 amRNSNew Product Launch
13th Aug 20254:20 pmRNSInvestor Meet Company Presentation Update
12th Aug 20257:00 amRNSLaunch of Compact Computer System
29th Jul 20257:00 amRNSNotice of Results and Investor Presentation
16th Jul 20255:25 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSH1 FY25 Trading Update
8th Jul 20252:13 pmRNSExercise of Options, New Ordinary Shares and TVR
1st Jul 20255:51 pmRNSHolding(s) in Company
25th Jun 20257:00 amRNSHolding(s) in Company
18th Jun 20252:19 pmRNSExercise of Options, New Ordinary Shares and TVR
13th Jun 20257:00 amRNSResults of Annual General Meeting
23rd May 20251:07 pmRNSExercise of Options, New Ordinary Shares and TVR
16th May 202510:53 amRNSPosting of Annual Report and Notice of AGM
15th May 20251:28 pmRNSHolding(s) in Company
8th May 20257:00 amRNSExercise of Options, New Ordinary Shares and TVR
28th Apr 20257:00 amRNSExercise of Options
24th Apr 20251:25 pmRNSExercise of Options, Director Dealing and TVR
23rd Apr 20254:01 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSFinal Results for the year ended 31 December 2024
7th Apr 20257:00 amRNSNotice of Results and Investor Presentation
31st Mar 20257:00 amRNSLease agreed for new HQ & manufacturing facility
17th Mar 202510:46 amRNSHolding(s) in Company
3rd Mar 20257:00 amRNSNew Product Announcement
28th Feb 20257:00 amRNSDirector Share Dealing
13th Feb 20257:00 amRNSCommencement of Trading on OTCQX in the U.S.
27th Jan 20257:00 amRNSMajor VME Product Order from Long-Term Customer
17th Jan 20259:22 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.